Advertisement

Jansen Jab Gets The EMA’s Go Ahead

The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the...

Share this article

09.41 21 Apr 2021


Jansen Jab Gets The EMA’s Go Ahead


Listen to this episode


Share this article

09.41 21 Apr 2021


The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the European Medicines Agency concluded yesterday. Concerns about the Jansen jab’s safety had been raised following reports of a small number of blood clots in US recipients. Professor of Experimental Immunology at Trinity College Dublin, Kingston Mills joined us this morning.

Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify.

   

Download, listen and subscribe on the Newstalk App.

  

You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.


Read more about

Breakfast Covid Vaccine Jansen Vaccine Johnson And Johnson Newstalk Newstalk Breakfast Vaccine

Related Episodes

Breakfast Briefing Newspaper R...

00:07:30

Breakfast Briefing Newspaper Review 14th May 2025

Breakfast Briefing

00:07:30


First Up- 14th May 2025

00:06:32

First Up- 14th May 2025

First Up – A GoLoud Original By Newstalk

00:06:32


Charlie Kelly Owner and Managi...

00:07:36

Charlie Kelly Owner and Managing Director of Explorium Science Museum

Breakfast Business With Joe Lynam

00:07:36


Quentin Werlé Head of Portfoli...

00:06:34

Quentin Werlé Head of Portfolio Management at the Luxembourg advisers 6 Monks

Breakfast Business With Joe Lynam

00:06:34